Henry Ford Health
Approved Enterprise Formulary
FormWeb QuickStart
Questions or Suggestions?
Pharmacy Shared Services Center
Search by name
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Biosimilar
Black Box Warning
Look Alike Sound Alike
Policy
REMS
Restricted Antimicrobials
Therapeutic Interchange
Hazardous Drugs
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
Boards
Brand name products with an equivalent generic may not be available to order at Henry Ford Health. For questions, contact inpatient pharmacy.
Henry Ford Health
Approved Enterprise Formulary
FormWeb QuickStart
Questions or Suggestions?
Pharmacy Shared Services Center
Search by name
Additional search options
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Biosimilar
Black Box Warning
Look Alike Sound Alike
Policy
REMS
Restricted Antimicrobials
Therapeutic Interchange
Hazardous Drugs
Search results for:
lenacapavir
lenacapavir
Drug Name
Form
Strength
Ambulatory Use Only
Ambulatory Restrictions
Inpatient Restrictions
Non-Formulary
Sunlenca
SOLUTION, SUBCUTANEOUS
kit containing two vials of 463.5 mg/1.5 mL
Yeztugo
SOLUTION, SUBCUTANEOUS
kit containing two vials of 463.5 mg/1.5 mL
VIEW MORE
anti-infectives
,
antiviral agents
Yeztugo is approved for use in ID Clinics only
Last updated:
Feb. 11, 2026
Black Box Warning
Risk of Drug Resistance With Use of Yeztugo for Hiv-1 Pre-Exposure Prophylaxis (Prep) In Undiagnosed Hiv-1 Infection
Micromedex
Clinical Pharmacology
FDA DailyMed
UpToDate Lexidrug
Add Formweb to your mobile device
Yeztugo is approved for use in ID Clinics only